Drug class
Small Interfering RNA; Aminolevulinate Synthase 1-directed RNA Interaction
Mechanism of action
Givosiran is a double-stranded small interfering RNA that causes degradation of aminolevulinate synthase 1 ( ALAS1 ) mRNA in hepatocytes through RNA interference, reducing the elevated levels of liver ALAS1 mRNA.
General use cases
- Porphyrias, Hepatic
- adults with acute hepatic porphyria (AHP)
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
